Vasopressin concentration in amniotic fluid as an index of fetal hypoxia: mechanism of release in sheep.
Hypoxia is a potent stimulus to the release of vasopressin in fetal sheep and, in turn, plasma concentrations of the hormone correlate inversely with fetal oxygenation. Because the fetal kidney contributes to vasopressin clearance, we propose that measurement of increased amounts of vasopressin in amniotic fluid would be indicative of fetal hypoxia. We therefore measured concentrations of vasopressin in amniotic fluid under resting conditions, during and after fetal hypoxia, and with intravenous and intra-amniotic administration of vasopressin in 15 chronically instrumented fetal lambs 111-141 d gestation. In the resting state mean (+/- SE) vasopressin concentrations in amniotic fluid (1.6 +/- 0.3 pg . ml-1) did not differ from those in maternal (1.4 +/- 0.4 pg . ml-1) or fetal (1.8 +/- 0.2 pg . ml-1) plasma. After exposure of the ewe to 10% O2 or partial occlusion of the umbilical cord, vasopressin concentrations in fetal plasma increased significantly (P less than 0.001) to 200 +/- 59 pg . ml-1 with a delayed increase in amniotic fluid concentrations (P less than 0.03) to 15.8 +/- 4.5 pg . ml-1. This rise in concentration of vasopressin in amniotic fluid was sustained for at least 24 h and levels at that time were highly correlated with peak plasma concentrations (r = 0.83, P less than 0.001). Intravenous infusion of vasopressin into the fetus was accompanied by an equally significant (P less than 0.02) and sustained increase of vasopressin in amniotic fluid. After intraamniotic injection of vasopressin, levels remained increased for at least 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)
D000653:Amniotic Fluid / Q000032:analysis* / Q000187:drug effects; D000818:Animals; D005260:Female; D005311:Fetal Hypoxia / Q000175:diagnosis*; D005333:Fetus / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D008470:Meconium / Q000378:metabolism; D011247:Pregnancy; D011863:Radioimmunoassay; D012756:Sheep / Q000502:physiology*; D013997:Time Factors; D014667:Vasopressins / Q000032:analysis* / Q000378:metabolism / Q000494:pharmacology
D014667:Vasopressins